Detecting cancer biomarkers (eg, circulating tumor cells, extracellular vehicles, nucleic
acids, and protein biomarkers) is vital for risk assessment and early diagnosis. Nanomaterial …

Nucleic acids are remarkable molecules. In addition to Watson–Crick base pairing, the
different structural motifs of these molecules can bind non‐nucleic acid targets or catalyze …

Over the past few years, the emergence of electrochemical wearable sensors has attracted
considerable attention because of their promising application in point‐of‐care testing due to …

Molecular diagnostics devoted to discover and monitor new biomarkers is gaining
increasing attention in clinical diagnosis. In this work, a programmable DNA-fueled …

Parkinson's disease (PD) is a progressive neurodegenerative disorder causing the loss of
dopaminergic neurons in the substantia nigra and the drastic depletion of dopamine (DA) in …

The current coronavirus disease 2019 (COVID-19) pandemic is caused by several variants
of severe acute respiratory syndrome coronavirus-2 virus (SARS-CoV-2). With the roll-out of …

Passivation of electrodes caused by nonspecific adsorption of protein can dramatically
reduce sensing sensitivity and accuracy, which is a great challenge for in vivo …

Sepsis is a life-threatening multi-organ failure syndrome, with bacterial infections being the
most common cause. Rapid Gram-typing is imperative to assist in antibiotic intervention. C …

The detection and/or quantification of biomarkers in blood is important for the early
detection, diagnosis, and treatment of a variety of diseases and medical conditions. Among …

Rapid, accurate diagnoses are central to future efficient healthcare to identify diseases at
early stages, avoid unnecessary treatment, and improve outcomes. Electrochemical …